| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02735694 Details | 2019-09-17 Interventional | 1 | 18 | Cycloserine Apnea Sleep Apnea Syn… | Analysis of initial sample shows negative results. - | |||
| NCT01891357 2012-003679-21 Details | 2019-09-17 Interventional | 2 | 64 | Lapatinib Paclitaxel Trastuzumab Carcinoma, Duct… Carcinoma, Duct… | Early termination due to significant lack of relevant patient data for evaluation of
objectives. Only a limited number of core biopsies was available evaluation of dynamic biological changes. Very slow patient recruitment. Negative study results from ALTTO study did no longer justify further conduct. | |||
| NCT00972023 Details | 2019-09-17 Interventional | 1 | 1 | Dehydroepiandro… Breast Neoplasm… Breast Cancer | - - | |||
| NCT03878654 Details | 2019-09-16 Interventional | 1 | 11 | Ursodoxicoltaur… Asthma | IRB protocol violations - | |||
| NCT02797704 Details | 2019-09-16 Interventional | 1/2 | [6 Refs] | 6 | Aflibercept Corneal Neovasc… Neovascularizat… | the treatment was found to be inefficient for all recruited patients - | ||
| NCT03182257 Details | 2019-09-13 Interventional | 1 | 1 | ONO-7579 Neoplasms Solid Tumor | The study was stopped for commercial reasons. No safety issues were reported. - | |||
| NCT01500785 2011-002643-10 Details | 2019-09-13 Interventional | 4 | 50 | Hydroxocobalami… Simendan Vitamin B 12 Myocardial Stun… | Change of schedule - | |||
| NCT00661973 2007-006664-29 Details | 2019-09-13 Interventional | 4 | 0 | Budesonide Asthma | The study was withdrawn for administrative reasons - | |||
| NCT03854942 Details | 2019-09-12 Interventional | 1 | 43 | Naltrexone Alcoholism Alcohol Addicti… | Recruitment rate could not be met in the study period, review group was dissolved before
regular end of study. Recruitment was therefore terminated. - | |||
| NCT03522987 Details | 2019-09-12 Interventional | 4 | 0 | Escitalopram Anxiety Disorde… Depression Depressive Diso… Epilepsy Anxiety | Decided not to perform the pilot phase - | |||
| NCT03291249 Details | 2019-09-12 Interventional | 2 | 0 | Omeprazole Diabetes Mellit… Diabetes Mellit… Fatty Liver Non-alcoholic F… NAFLD NASH - Nonalcoh… T2DM (Type 2 Di… | Due to MOH request. - | |||
| NCT02011620 Details | 2019-09-11 Interventional | 4 | 0 | Isosorbide Isosorbide Dini… Isosorbide-5-mo… Bone Diseases Diabetes Mellit… Diabetes Mellit… Bone Disease Endothelial Dys… | The sponsor was no longer in a position to sponsor a CTIMP. Study did not open. - | |||
| NCT03397186 Details | 2019-09-10 Interventional | 2 | 0 | Trabectedin Liposarcoma Liposarcoma, My… Sarcoma Metastatic Soft… Myxoid Liposarc… Round Cell Lipo… Stage III Soft … Stage IV Soft T… Unresectable So… | Administrative - | |||
| NCT02688764 Details | 2019-09-10 Interventional | 3 | 85 | Calcium Calcium acetate Hyperphosphatem… | The study was prematurely ended due to the modification of study requirements by the US Food
and Drug Administration and the European Medicines Agency The study was prematurely ended as a result of the modification of study requirements, as agreed with the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). | |||
| NCT02615938 2013-003714-40 Details | 2019-09-10 Interventional | 2 | - | Hydroxychloroqu… Lung Diseases Lung Diseases, … Children´s Int… Diffuse Parench… Interstitial Lu… | Correction of inspection findings - | |||
| NCT02187367 2013-005335-25 Details | 2019-09-10 Interventional | 3 | 106 | Cyclophosphamid… Carcinoma, Non-… | Sponsor decision based on slow recruitment and new emerging drug combinations - | |||
| NCT02058108 2012-004942-14 Details | 2019-09-10 Interventional | 3 | 53 | Telbivudine Hepatitis Hepatitis A Hepatitis B Hepatitis B, Ch… Hepatitis, Chro… Herpesviridae I… Virus Diseases Chronic Hepatit… | Study terminated on the recommendation of an independent Data Monitoring Committee (DMC)
subsequent to an interim efficacy analysis for futility.] Due to early termination of the study and limited number of enrolled patients on track to complete 52 weeks of participation (8 patients overall), no formal analysis of Weeks 52 and 104 long-term efficacy endpoints (only descriptive analysis). | |||
| NCT03638635 Details | 2019-09-09 Interventional | 4 | 63 | Bupivacaine Pain, Postopera… Colectomy Colorectal Surg… Opioid Use | Lack of personnel available to complete study. Early termination due to lack of resources leading to incomplete data. | |||
| NCT02772120 Details | 2019-09-09 Interventional | 4 | 0 | Progesterone Infertility | Before enrollment, suspended due to changing insurance coverage of study drugs. - | |||
| NCT02289274 Details | 2019-09-09 Interventional | 1 | 0 | Aceclofenac Eperisone Healthy | internal decision - |